Rubina Parmar

1.0k total citations
11 papers, 569 citations indexed

About

Rubina Parmar is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Rubina Parmar has authored 11 papers receiving a total of 569 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Cancer Research and 1 paper in Genetics. Recurrent topics in Rubina Parmar's work include RNA Interference and Gene Delivery (11 papers), Advanced biosensing and bioanalysis techniques (9 papers) and MicroRNA in disease regulation (4 papers). Rubina Parmar is often cited by papers focused on RNA Interference and Gene Delivery (11 papers), Advanced biosensing and bioanalysis techniques (9 papers) and MicroRNA in disease regulation (4 papers). Rubina Parmar collaborates with scholars based in United States and Netherlands. Rubina Parmar's co-authors include Muthiah Manoharan, Martin A. Maier, Vasant Jadhav, Kallanthottathil G. Rajeev, Jennifer L. S. Willoughby, Christopher S. Theile, Ivan Zlatev, Christopher R. Brown, Carole E. Harbison and Klaus Charissé and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Chemical Communications.

In The Last Decade

Rubina Parmar

11 papers receiving 558 citations

Peers

Rubina Parmar
Stephanie Bertin United States
Rubina Parmar
Citations per year, relative to Rubina Parmar Rubina Parmar (= 1×) peers Stephanie Bertin

Countries citing papers authored by Rubina Parmar

Since Specialization
Citations

This map shows the geographic impact of Rubina Parmar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rubina Parmar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rubina Parmar more than expected).

Fields of papers citing papers by Rubina Parmar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rubina Parmar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rubina Parmar. The network helps show where Rubina Parmar may publish in the future.

Co-authorship network of co-authors of Rubina Parmar

This figure shows the co-authorship network connecting the top 25 collaborators of Rubina Parmar. A scholar is included among the top collaborators of Rubina Parmar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rubina Parmar. Rubina Parmar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Parmar, Rubina, Klaus Charissé, Laura Sepp‐Lorenzino, et al.. (2022). Efficient Downregulation of Alk4 in Skeletal Muscle After Systemic Treatment with Conjugated siRNAs in a Mouse Model for Duchenne Muscular Dystrophy. Nucleic Acid Therapeutics. 33(1). 26–34. 11 indexed citations
2.
Goldberg, Shalom D., Christopher S. Theile, Kathleen Haskell, et al.. (2021). Centyrin ligands for extrahepatic delivery of siRNA. Molecular Therapy. 29(6). 2053–2066. 33 indexed citations
3.
Kumar, Pawan, Rubina Parmar, Christopher R. Brown, et al.. (2019). 5′-Morpholino modification of the sense strand of an siRNA makes it a more effective passenger. Chemical Communications. 55(35). 5139–5142. 29 indexed citations
4.
Janas, Maja M., Mark K. Schlegel, Carole E. Harbison, et al.. (2018). Selection of GalNAc-conjugated siRNAs with limited off-target-driven rat hepatotoxicity. Nature Communications. 9(1). 723–723. 200 indexed citations
5.
Parmar, Rubina, Christopher R. Brown, Shigeo Matsuda, et al.. (2018). Facile Synthesis, Geometry, and 2′-Substituent-Dependent in Vivo Activity of 5′-(E)- and 5′-(Z)-Vinylphosphonate-Modified siRNA Conjugates. Journal of Medicinal Chemistry. 61(3). 734–744. 38 indexed citations
6.
Elkayam, Elad, Rubina Parmar, Christopher R. Brown, et al.. (2016). siRNA carrying an (E)-vinylphosphonate moiety at the 5΄ end of the guide strand augments gene silencing by enhanced binding to human Argonaute-2. Nucleic Acids Research. 45(6). 3528–3536. 67 indexed citations
7.
Parmar, Rubina, Jennifer L. S. Willoughby, Jingxuan Liu, et al.. (2016). 5′‐(E)‐Vinylphosphonate: A Stable Phosphate Mimic Can Improve the RNAi Activity of siRNA–GalNAc Conjugates. ChemBioChem. 17(11). 985–989. 105 indexed citations
8.
Zlatev, Ivan, Donald J. Foster, Jingxuan Liu, et al.. (2015). 5′-C-Malonyl RNA: Small Interfering RNAs Modified with 5′-Monophosphate Bioisostere Demonstrate Gene Silencing Activity. ACS Chemical Biology. 11(4). 953–960. 17 indexed citations
9.
Guidry, Erin N., Arash Soheili, Craig A. Parish, et al.. (2014). Improving the In Vivo Therapeutic Index of siRNA Polymer Conjugates through Increasing pH Responsiveness. Bioconjugate Chemistry. 25(2). 296–307. 15 indexed citations
10.
Parmar, Rubina, Jonathan Williams, R. M. Garbaccio, et al.. (2014). Novel Endosomolytic Poly(amido amine) Polymer Conjugates for Systemic Delivery of siRNA to Hepatocytes in Rodents and Nonhuman Primates. Bioconjugate Chemistry. 25(5). 896–906. 21 indexed citations
11.
Parmar, Rubina, Eileen S. Walsh, Karen Leander, et al.. (2013). Endosomolytic Bioreducible Poly(amido amine disulfide) Polymer Conjugates for the in Vivo Systemic Delivery of siRNA Therapeutics. Bioconjugate Chemistry. 24(4). 640–647. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026